GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Harbin Pharmaceutical Group Co 600664.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

5.69

+2.52%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥15.96bn

FY2016FY2025

Net income

CN¥361.6m

FY2016FY2025

Free cash flow

CN¥288.7m

FY2016FY2025

Shareholders' equity

CN¥5.69bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥15.96bnCN¥16.18bnCN¥15.46bnCN¥13.81bnCN¥12.80bnCN¥10.79bnCN¥11.82bnCN¥10.81bnCN¥12.02bnCN¥14.13bn
Gross profitCN¥4.15bnCN¥4.52bnCN¥4.01bnCN¥3.36bnCN¥2.98bnCN¥2.25bnCN¥2.80bnCN¥2.90bnCN¥3.11bnCN¥3.70bn
Research and developmentCN¥145.0mCN¥136.4mCN¥106.0mCN¥115.8mCN¥97.7mCN¥92.5mCN¥125.1mCN¥137.3mCN¥142.1mCN¥177.8m
Operating incomeCN¥730.5mCN¥890.2mCN¥659.6mCN¥695.8mCN¥642.4m−CN¥942.1mCN¥277.7mCN¥527.4mCN¥655.9mCN¥997.2m
Net incomeCN¥361.6mCN¥628.8mCN¥395.3mCN¥465.2mCN¥371.1m−CN¥1.08bnCN¥55.8mCN¥346.1mCN¥407.0mCN¥788.1m
Diluted earnings per share0.140.240.160.180.15-0.400.030.140.160.32

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥14.29bnCN¥14.62bnCN¥14.11bnCN¥13.44bnCN¥12.84bnCN¥11.85bnCN¥12.50bnCN¥11.90bnCN¥13.70bnCN¥15.05bn
Cash and short-term investments—CN¥3.63bnCN¥3.06bnCN¥2.43bnCN¥1.59bnCN¥897.0mCN¥675.5mCN¥2.05bnCN¥3.51bnCN¥4.64bn
Total liabilitiesCN¥7.83bnCN¥8.53bnCN¥8.69bnCN¥8.48bnCN¥8.42bnCN¥7.86bnCN¥6.56bnCN¥5.62bnCN¥6.22bnCN¥6.75bn
DebtCN¥31.5mCN¥1.62bnCN¥1.72bnCN¥2.16bnCN¥2.31bnCN¥1.77bnCN¥673.1mCN¥254.2mCN¥262.2mCN¥148.3m
Shareholders' equityCN¥5.69bnCN¥5.35bnCN¥4.72bnCN¥4.33bnCN¥3.85bnCN¥3.48bnCN¥5.46bnCN¥5.87bnCN¥7.05bnCN¥7.85bn
Shares outstanding2,519m2,589m2,519m2,614m2,511m2,666m2,148m2,538m2,493m2,491m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥439.7mCN¥792.5mCN¥949.7mCN¥622.1m−CN¥162.4m−CN¥728.2m−CN¥284.9mCN¥692.7mCN¥149.2mCN¥2.78bn
Capital spending−CN¥150.9m−CN¥100.8m−CN¥86.5m−CN¥89.6m−CN¥76.7m−CN¥118.2m−CN¥39.0m−CN¥114.1m−CN¥102.0m−CN¥107.5m
Free cash flowCN¥288.7mCN¥691.7mCN¥863.1mCN¥532.4m−CN¥239.1m−CN¥846.4m−CN¥323.9mCN¥578.6mCN¥47.2mCN¥2.67bn
Dividends paid−CN¥33.3m−CN¥47.1m−CN¥44.2m−CN¥54.3m−CN¥61.5m−CN¥24.1m−CN¥10.3m−CN¥1.35bn−CN¥1.35bn−CN¥83.5m

Latest quarters

By quarter end

Sept 2026Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024
RevenueCN¥4.06bnCN¥4.12bnCN¥4.18bnCN¥3.94bnCN¥3.90bnCN¥3.95bnCN¥4.17bnCN¥3.92bn
Gross profitCN¥1.05bnCN¥1.18bnCN¥1.01bnCN¥1.02bnCN¥931.2mCN¥1.06bnCN¥1.11bnCN¥1.06bn
Operating incomeCN¥283.5mCN¥309.4mCN¥236.4mCN¥140.7mCN¥97.4mCN¥94.2mCN¥272.1mCN¥168.6m
Net incomeCN¥189.9mCN¥249.2mCN¥161.1mCN¥33.0mCN¥68.9mCN¥46.8mCN¥212.9mCN¥120.6m
Diluted earnings per share0.080.100.060.010.030.020.080.05
Cash from operations————−CN¥192.0mCN¥323.0m−CN¥464.0m—
Capital spending−CN¥34.0m−CN¥42.0m−CN¥21.0m−CN¥77.0m−CN¥33.0m−CN¥20.0m−CN¥19.0m−CN¥34.0m
Free cash flow————−CN¥225.0mCN¥303.0m−CN¥483.0m—
Total assetsCN¥14.90bnCN¥14.64bnCN¥14.65bnCN¥14.29bnCN¥14.08bnCN¥14.03bnCN¥14.09bnCN¥14.62bn
Cash and short-term investments————CN¥2.74bnCN¥3.05bnCN¥2.80bnCN¥3.63bn
DebtCN¥31.6mCN¥31.6mCN¥31.5mCN¥31.5mCN¥2.70bnCN¥1.14bnCN¥1.18bnCN¥1.59bn
Shareholders' equityCN¥6.30bnCN¥6.11bnCN¥5.86bnCN¥5.69bnCN¥5.66bnCN¥5.61bnCN¥5.56bnCN¥5.35bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.0%8.2%0.1%
Operating income1.6%—-0.1%
Net income-8.1%—-4.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin27.0%26.1%25.0%25.2%
Operating margin5.0%4.8%3.1%3.9%
Net margin3.1%3.0%1.3%2.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings24.117.021.416.924.0-7.9145.829.035.727.1
Price to sales0.60.70.60.60.70.80.70.91.21.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 4 May 2018.

FY2018FY2017FY2015FY2014FY2011FY2010FY2009FY2008
Paid in the year0.500.500.7690.0510.3430.290.3490.059
  • 13-for-10 split · 6 Apr 2016
  • 13-for-10 split · 1 Aug 2011
  • 13-for-10 split · 13 Aug 2004
  • 3-for-2 split · 17 Jul 2003
  • 6-for-5 split · 12 Jul 2002
  • 13-for-10 split · 24 Apr 1997

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.